title: Long-term survival after allogeneic-matched sibling PBSC transplantation with conditioning consisting of low-dose busilvex and fludarabine in a 3-year-old boy with ataxia-telangiectasia syndrome and ALL.
authors.forename: M
authors.initials: M
authors.lastname: Ussowicz
authors.forename: J
authors.initials: J
authors.lastname: Musiał
authors.forename: E
authors.initials: E
authors.lastname: Duszeńko
authors.forename: O
authors.initials: O
authors.lastname: Haus
authors.forename: K
authors.initials: K
authors.lastname: Kałwak
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001260:Ataxia Telangiectasia / Q000188:drug therapy* / Q000601:surgery*; D002066:Busulfan / Q000008:administration & dosage; D002675:Child, Preschool; D006801:Humans; D008297:Male; D036102:Peripheral Blood Stem Cell Transplantation / Q000379:methods*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000601:surgery*; D035781:Siblings; D016019:Survival Analysis; D014019:Tissue Donors; D019172:Transplantation Conditioning / Q000379:methods; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives
chemical_list: D014740:Vidarabine; D002066:Busulfan; C024352:fludarabine